GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Inventories, Finished Goods

JW Pharmaceutical (XKRX:001060) Inventories, Finished Goods : ₩71,618 Mil (As of Mar. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Inventories, Finished Goods?

JW Pharmaceutical's quarterly finished goods increased from Sep. 2023 (₩65,623 Mil) to Dec. 2023 (₩68,316 Mil) and increased from Dec. 2023 (₩68,316 Mil) to Mar. 2024 (₩71,618 Mil).

JW Pharmaceutical's annual finished goods increased from Dec. 2021 (₩63,167 Mil) to Dec. 2022 (₩69,069 Mil) but then declined from Dec. 2022 (₩69,069 Mil) to Dec. 2023 (₩68,316 Mil).


JW Pharmaceutical Inventories, Finished Goods Historical Data

The historical data trend for JW Pharmaceutical's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Inventories, Finished Goods Chart

JW Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 59,206.42 69,557.53 63,166.52 69,068.92 68,315.54

JW Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71,088.32 72,517.98 65,622.78 68,315.54 71,617.50

JW Pharmaceutical Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


JW Pharmaceutical (XKRX:001060) Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines